Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | VDR | P11473 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | CCR4 | P51679 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17017793 | 0.96 | MEN1 (0.36) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17017775 | 0.96 | MEN1 (0.35) | MEN1KMT2AATMKDM1AABCG2 | |
| SCHEMBL17017764 | 0.94 | MEN1 (0.40) | MEN1KMT2AATMKDM1AABCG2 | |
| SCHEMBL17017771 | 0.93 | MEN1 (0.39) | MEN1KMT2AATMABCG2CYP1A2 | |
| SCHEMBL17017778 | 0.93 | MEN1 (0.34) | MEN1KMT2AATMABCG2ADORA2A | |
| SCHEMBL17017728 | 0.93 | ATM (0.37) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17017672 | 0.91 | MEN1 (0.37) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17017767 | 0.91 | MEN1 (0.34) | MEN1KMT2AATMABCG2GAA | |
| SCHEMBL17017774 | 0.90 | MEN1 (0.36) | MEN1KMT2AATM | |
| SCHEMBL17017749 | 0.90 | KMT2A (0.38) | MEN1KMT2AATMKDM1AABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9905777-B2 | Compound and organic electroluminescence device comprising same | DOOSAN CORPORATION (KR) | 2018-02-27 | — | — | US | disclosed |
| US-9905777-B2 | Compound and organic electroluminescence device comprising same | DOOSAN CORPORATION (KR) | 2018-02-27 | — | — | US | disclosed |
| US-20150236271-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2015-08-20 | — | — | US | disclosed |
| US-20150236271-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150236271-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME | OR10J3, VDAC1, VDAC2 | MEN1 1762/4885KMT2A 1420/4885ATM 3382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.